Skip to main content
OpenTrials

Clinical trial condition

Papillomavirus Infections

Explore clinical trials studying Papillomavirus Infections. Study availability and eligibility vary by location and protocol.

438 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Papillomavirus Infections trial results

Completed

A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years

NCT00485732

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Seoul, South Korea
  • GSK Investigational Site Seoul, South Korea
  • GSK Investigational Site Seoul, South Korea
  • GSK Investigational Site Seoul, South Korea
View Trial Details
Completed

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

NCT00369824

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +24 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
View all 50 locations
View Trial Details
Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects

NCT00426361

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations
  • GSK Investigational Site Auch, France
  • GSK Investigational Site Draguignan, France
  • GSK Investigational Site Essey-lès-Nancy, France
  • GSK Investigational Site Évreux, France
View all 38 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

NCT02724254

Conditions
Communicable Diseases, Condyloma, Condylomata Acuminata, +17 more
Locations
  • Anaconda Invesigational Site Buenos Aires, Argentina
  • Anaconda Investigational Site Buenos Aires, Argentina
  • Anaconda Investigational Site Córdoba, Argentina
  • Anaconda Investigational Site Mendoza, Argentina
View Trial Details
Completed

Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study

NCT01418937

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations
  • GSK Investigational Site Porto Alegre, Rio Grande do Sul, Brazil
  • GSK Investigational Site Campinas, Brazil
  • GSK Investigational Site Curitiba, Brazil
  • GSK Investigational Site Fortaleza, Brazil
View Trial Details
Completed

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US

NCT00799825

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site San Diego, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Louisville, Colorado, United States
View all 48 locations
View Trial Details

Related conditions